8:30am
Opening Remarks
Susan M. Wolf, JD, University of Minnesota
Welcome
Mihail C. Roco, PhD, National Science Foundation (NSF)
View video
8:45am
Translation of Nanotherapeutics and Nanodiagnostics to Clinical Practice: Overview and Examples
Moderator: Susan M. Wolf, JD, University of Minnesota
Samuel Wickline, MD, Washington University in St. Louis
View video
9:15am
The Challenges Posed by Nanomedicine Research in Human Beings
Andrew Maynard, PhD, University of Michigan
View video
9:45am
Discussion
View video
10:00am
Break
10:15am
Ethical Conduct and Oversight of Human Subjects Research in Nanomedicine: Project Analysis & Recommendations
Susan M. Wolf, JD, University of Minnesota
Leili Fatehi, JD, University of Minnesota
Frances P. Lawrenz, PhD, University of Minnesota
Jeffrey McCullough, MD, University of Minnesota Medical School
Jeffrey P. Kahn, PhD, MPH, University of Minnesota
Ralph Hall, JD, University of Minnesota Law School
View video
10:45am
Panel—Reaction to Recommendations
Moderator: Frances Lawrenz, PhD, University of Minnesota
Panelists:
Mihail C. Roco, PhD, National Science Foundation (NSF)
John Howard, MD, MPH, JD, LLM, National Institute for Occupational Safety and Health (NIOSH)
Jerry Menikoff, MD, JD, MPP, U.S. Department of Health & Human Services
Jeffrey A. Schloss, PhD, National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH)
R. Alta Charo, JD, University of Wisconsin-Madison
Warren Lux, MD, U.S. Environmental Protection Agency (EPA)
View video
12:15pm
Networking Lunch
1:00pm
Concurrent Workshops
Session A: Defining the Problem & Core Risks
Moderator: Jeffrey McCullough, MD, University of Minnesota
Panelists:
Jeffrey McCullough, MD, and Michael Etheridge, MSME and MS candidate, University of Minnesota, on “Mapping the Nanomedicine Landscape”
View video
Ron Siegel, ScD, University of Minnesota, on “What Is Unique About Nanomedicine? The Significance of the Meso-Scale”
View video
Andrew Maynard, PhD, University of Michigan, on “Proposals for Governance of Nanomedicine Research”
View video
Christy Haynes, PhD, Professor of Chemistry, University of Minnesota, (paper with Melissa Mauer-Jones, PhD candidate, Chemistry, University of Minnesota) on “Discrepancies in In Vivo and In Vitro Nanotoxicology Studies”
View video
Robert Hoerr, MD, PhD, Nanocopoeia, Inc., on “Collaborative Governance of Nanomedicine in the Face of Uncertainty”
View video
Q&A
View video
Session B: First-in Human Research
Moderator: Jeffrey P. Kahn, PhD, MPH, and Ralph Hall, JD, University of Minnesota
Panelists:
Jerry Menikoff, MD, JD, MPP, OHRP, U.S. Department of Health & Human Services, on “Nanomedicine First-in-Human Research: OHRP Oversight”
View video
Rebecca Dresser, JD, Washington University in St. Louis, on “Building an Ethical Foundation for First-in-Human Nanotrials”
View video
Efrosini Kokkoli, PhD, University of Minnesota, on “What Does Pre-Clinical Research Tell Us About Moving Into Humans”
View video
Nancy M.P. King, PhD, Wake Forest University School of Medicine, on “Nanomedicine First-in-Human Research: Challenges to Informed Consent”
View video
Q&A
View video
2:30pm
Break
2:45pm
Concurrent Workshops
Session C: Human Subjects Protection
Moderator: Susan M. Wolf, JD, University of Minnesota
Panelists:
Ralph Hall, JD, University of Minnesota, on “FDA Approaches to Protecting Human Subjects in Nanomedicine Trials”
View video
Frances Lawrenz, PhD, University of Minnesota, on “Current Approaches to Oversight of Human Subjects Research in Nanomedicine”
View video
Gary Marchant, JD, PhD, MPP, Arizona State University, on “Applying Prudent Precaution to Nanomedicine Clinical Trials”
View video
Jeffrey P. Kahn, PhD, MPH, University of Minnesota, on “Models of Exceptional Oversight for Nanomedicine”
View video
Susan M. Wolf, JD, and Cortney Jones, JD, University of Minnesota, on “Designing Oversight for Nanomedicine Research in Human Subjects: Systematic Analysis of Exceptional Oversight for Emerging Technologies”
View video
Q&A
View video
Session D: Beyond the Common Rule
Moderator: Moira Keane, MA, University of Minnesota
Panelists:
Jonathan Kimmelman, PhD, McGill University, on “Predicting Ethical and Safety Risks to Bystanders from Nanomedicine Research”
View video
David Resnik, JD, PhD, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), on “Responsible Conduct in Nanomedicine Research: Concerns Beyond the Common Rule”
View video
Moira Keane, MA, CIP, University of Minnesota, on “Institutional Oversight of Nanomedicine Human Subjects Research: From the IRB to the IBC and Beyond”
View video
Gurumurthy Ramachandran, PhD, University of Minnesota, on “Handling Worker and Third-Party Exposures in Nanomedicine Research”
View video
Arthur Erdman, PhD, University of Minnesota, on “Nanomedicine Commercialization Issues, including Barriers to Start-Up Companies”
View video
Q&A
View video
4:15pm
Reports from Concurrent Sessions and Next Steps
Workshop Moderators
View video
4:45pm
Reception